Enhancement of in-Vitro GC Function in Patients With COPD
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The investigator wish therefore to continue these studies on theophylline principally by
conducting a small clinical pilot study on 20-30 COPD patients in a randomised, double-blind,
placebo-controlled, parallel-group study.
Phase:
Phase 2
Details
Lead Sponsor:
Imperial College London
Collaborators:
Medical Research Council Mitsubishi Tanabe Pharma Corporation